Evopoint Biosciences Co., Ltd. (SHA:688837)
China flag China · Delayed Price · Currency is CNY
33.98
-1.23 (-3.49%)
Nov 17, 2026, 3:00 PM CST

Evopoint Biosciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
234.75935.24--19.5
Revenue Growth
-----
Gross Profit
234.75935.24--19.5
Operating Income
-468.1210.11-462.1-450.16-522.56
Net Income
-453.17202.56-386-426.89-462.63
Earnings Per Share
-1.220.55-1.05-1.25-1.42
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
2,579818.39383.42530.47429.37
Total Debt
1,318898.25521.48412.22360.67
Net Cash (Debt)
1,261-79.86-138.05118.2468.7
Net Cash Growth
---72.11%-
Net Cash Per Share
3.40-0.22-0.380.350.21

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-477.43178.3-349.49-370.55-418.55
Capital Expenditures
-52.43-62.64-50.08-90.13-162.2
Free Cash Flow
-529.87115.66-399.57-460.68-580.75
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%--100.00%
Operating Margin
-199.41%22.47%---2679.80%
Pretax Margin
-185.74%31.57%---2372.47%
Profit Margin
-193.05%21.66%---2372.47%
FCF Margin
-225.72%12.37%---2978.22%